The role of adjunctive therapies for people with type 1 diabetes
ATTD 2019 - BERLIN
ATTD: time in range recommendations by the Consensus Group
en
Prof. Tadej Battelino
Role and function of the ATTD yearbook
en
Prof. Moshe Phillip
The role of adjunctive therapies for people with type 1 diabetes
en
Prof. Satish Garg
SGLT in T1D: "STICH Protocol" for mitigating risk of ketoacidosis
en
Dr. Thomas Danne
New insulins, biosimilars, and insulin therapy
en
Prof. Lutz Heinemann
The importance of the titration period for basal insulin initiation
en
Dr. Robert A. Ritzel
Predictive insulin suspension prevents hypoglycemia
en
Dr. Pratik Choudhary
Brain and cognitive consequences of type 1 diabetes in children
en
Prof. Stuart Weinzimer
Con nuovi microinfusori e app dedicate, controllo glicemico ottimale
it
Dr. Andrea Scaramuzza
New mealtime insulins: pharmacokinetic and pharmacodynamic data
en
Prof Christophe De Block
Diabetes technologies need doctor and patient structured education
it
Prof. Olga Kordonouri
New devices for T1D: the experience at the Schneider Institute
en
Dr. Nimri Revital
Subcutaneous CGM sensor / 6 months: a revolution for patient and doctor
en
Dr. Concetta Irace
Sensore CGM sottocutaneo/6 mesi: una rivoluzione per paziente e medico
it
Dr. Concetta Irace
Bambino diabetico: distress mitigato da efficacia dei nuovi device
it
Dr. Vincenzo Provenzano